CGC Financial Services’s NovoCure NVCR Stock Holding History

CGC Financial Services’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.79K	Buy	+300	New	+$5.01K	﹤0.01%	263
2025 Q2	–	Sell	-30	Closed	-$535	–	341
2025 Q1	$535	Hold	30	–	–	﹤0.01%	307
2024 Q4	$894	Hold	30	–	–	﹤0.01%	305
2024 Q3	$469	Hold	30	–	–	﹤0.01%	315
2024 Q2	$514	Hold	30	–	–	﹤0.01%	313
2024 Q1	$469	Hold	30	–	–	﹤0.01%	325
2023 Q4	$448	Hold	30	–	–	﹤0.01%	336
2023 Q3	$485	Hold	30	–	–	﹤0.01%	293
2023 Q2	$1.25K	Buy	+30	New	+$1.86K	﹤0.01%	282

Other funds holding NVCR

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

AWA

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CGC Financial Services's NVCR Position: Q3 2026 in Review

CGC Financial Services opened a new position in NovoCure (NVCR) in Q3 2026: 300 shares worth $4.79K. The stake represents ﹤0.01% of the portfolio and ranks #263 among its holdings. This is a return to the name: CGC Financial Services previously reported a position in NVCR as recently as Q1 2025.

CGC Financial Services first reported a position in NVCR in Q2 2023 and has held it in 9 quarters since. 16 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

CGC Financial Services held 300 shares of NovoCure worth $4.79K as of Q3 2026.
NovoCure was a new CGC Financial Services position in Q3 2026.
NovoCure made up ﹤0.01% of CGC Financial Services's portfolio in Q3 2026, its #263 holding.
CGC Financial Services first reported a position in NovoCure in Q2 2023 and has held it in 9 quarters since.
16 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on CGC Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.